CN Stock MarketDetailed Quotes

603367 Cisen Pharmaceutical

Watchlist
  • 14.71
  • -0.08-0.54%
Not Open Nov 13 15:00 CST
6.66BMarket Cap12.59P/E (TTM)

About Cisen Pharmaceutical Company

The company is currently listed on the main board of the Shanghai Stock Exchange. It is a comprehensive pharmaceutical enterprise integrating R&D, production and sales. The company was founded in 1970, and its predecessor was Jining No. 3 Pharmaceutical Factory. The company's main business involves R&D, production and sales of pharmaceuticals. The company's main products: large infusion-glass bottles, large infusion-non-PVC soft packs, large infusion-plastic bottles, small-volume injections, oral solid preparations, freeze-dried powder injections, drops, pastes, raw materials, rinsing agents. The company has received honors such as National Contract-abiding and Credit-worthy Enterprise, 2014 Pharmaceutical Industry Innovative Excellent Enterprise Brand, 2014 Pharmaceutical Industry Top 100 Comprehensive Strength Enterprise, and AAA Credit Enterprise.

Company Profile

Short Name-A辰欣药业
Symbol-A603367
Company NameCisen Pharmaceutical Co., Ltd.
Listing DateSep 29, 2017
Issue Price11.66
Shares Offered100.00M share(s)
FoundedNov 6, 1998
Listed ExchangeSH Stock Exchange
Legal Representativezhenxin du
General Managerzhenxin du
Secretaryxinbing xu
Accounting FirmDaxin Certified Public Accountants (Special General Partnership)
Securities Representativewei sun
Legal CounselShandong Guoyao Qindao (Jinan) Law Firm
Employees2753
Phone0537-2989906
Office AddressNo. 16, Tongji Road, High-tech Zone, Jining City, Shandong Province
Zip Code272073
Registered AddressTongji Science and Technology Industrial Park, High-tech Zone, Jining, Shandong
Emailcxyy@cisenyy.com
Business License370833018004046
BusinessLicense projects: pharmaceutical production; drug contract production; pharmaceutical wholesale; drug retail; production of formula food for special medical purposes; food production; health food production; beverage production; food additive production; pharmaceutical import and export; veterinary drug production; veterinary drug business. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to documents or licenses approved by relevant departments) General projects: sale of formula food for special medical purposes; food sales (sale of only pre-packaged food); sales of health food (pre-packaged food only); sales of food additives; import and export of goods; medical research and experimental development; technical services, technology development, technical consultation, technical exchange, technology transfer and technology promotion; investment activities with own capital. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)

Company Executives

  • Name
  • Position
  • Salary
  • zhenxin du
  • Chairman, Directors, General Manager, Chairman of the Strategy Committee
  • 971.80K
  • xiulian lu
  • Directors, Deputy General Manager, Chief Engineer, Strategy Committee Member
  • 620.30K
  • pengmei tian
  • Directors, Nomination Committee Members
  • 120.00K
  • xinbing xu
  • Directors, Board Secretary, Chief Financial Officer, Member of the Remuneration and Assessment Committee
  • 266.60K
  • liushan hao
  • Directors, Deputy General Manager, Strategy Committee Member
  • 695.30K
  • baozhan huang
  • Directors, Audit Committee Member
  • --
  • ziran zhang
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
  • --
  • weijia wang
  • Independent Directors, Audit Committee Member, Chairman of the Nomination Committee
  • --
  • wenchun cai
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • --
  • wei sun
  • Securities Affairs Representative
  • --
  • enlong zhao
  • Chairman of the Supervisory Board, Auditors
  • 235.10K
  • xiang liu
  • Auditors
  • 96.50K
  • zelin ren
  • Deputy General Manager
  • --
  • xiaoting cui
  • Deputy General Manager
  • 654.80K
  • xianglin zhang
  • Deputy General Manager
  • 655.40K
  • yan liu
  • Employee Supervisors
  • 83.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data